Seqirus announces positive CHMP Opinion for its adjuvanted quadrivalent influenza vaccine

31 March 2020 - Seqirus today announced that its adjuvanted quadrivalent influenza vaccine - launching as Fluad Tetra - has received ...

Read more →

Eleven states now letting uninsured sign up for Obamacare

23 March 2020 - More coronavirus care will be covered in many states. Federal officials are considering similar action for the ...

Read more →

COVID-19: an update from Dr. Brian O’Rourke, CADTH President and CEO

18 March 2020 - As our country deals with the COVID-19 situation, CADTH has implemented several initiatives to mitigate the ...

Read more →

Insulin costs may be capped in a Medicare program

11 March 2020 - If drug companies and insurers agree to participate, the Trump administration proposes limiting insulin costs to $35 ...

Read more →

Population-based payments may help ensure access to life-saving antibiotics for Medicare beneficiaries

18 February 2020 - In 2019, the Centers for Disease Control and Prevention (CDC) released an updated report on Antibiotic Resistance ...

Read more →

How protected classes in Medicare Part D influence U.S. drug sales, utilisation, and price

13 February 2020 - When the Medicare Part D prescription drug benefit was implemented in 2006, six drug classes were designated ...

Read more →

Proposed changes to Medicare Advantage and Part D will provide better coverage, more access and improved transparency for Medicare beneficiaries

5 February 2020 - Proposed rule and Advance Notice continue to strengthen the popular private Medicare health and drug plans. ...

Read more →

European Commission approves Roche’s Polivy for people with previously treated aggressive lymphoma

21 January 2020 - Novel combination regimen includes first-in-class antibody-drug conjugate that specifically targets CD79b. ...

Read more →

Can we please stop fighting about ‘Medicare for all’?

8 January 2020 - One policy proposal has defined this Democratic race. It’s time to move on. ...

Read more →

Who pays in Medicare Part D? Giving plans more skin in the game.

19 December 2019 - As U.S. policy makers debate proposals for reforming the prescription-drug marketplace, they should recognise the need to ...

Read more →

Medicare costs for seniors lowered in Senate drug price bill

7 December 2019 - Seniors would pay a smaller portion of their drugs’ cost and be shielded from huge one-time ...

Read more →

Pelosi sets Medicare showdown on drug costs and new benefits

6 December 2019 - The House will hold a showdown vote next week on Speaker Nancy Pelosi’s bill empowering Medicare ...

Read more →

Medicare bill ‘puts every Australian at risk’

28 November 2019 - A new Medicare anti-fraud bill would put the privacy of every Australian at risk and create ...

Read more →

Pricing tactics slow uptake of generic drugs by Medicare plans

21 November 2019 - Study finds new copycat medicines take years to win coverage. ...

Read more →

Elizabeth Warren says ‘Medicare for All’ rollout process will take 3 years

16 November 2019 — Elizabeth Warren announced Friday that she would expand public health insurance during her first 100 days ...

Read more →